Purpose: Clinical studies have revealed that the most important predictor of successful bypass grafting is the origin and quality of the bypass conduit. Attempts at intraoperative evaluation of the hemodynamic properties of the conduit, including assessment of blood flow (Q), pressure gradients (Ap), and resistance (R), have not been useful. This is because each of these parameters measures the characteristics of the graft plus the outflow bed. To date, no specific measurement of the resistive properties of the conduit only is available. The purpose of this investigation was to evaluate longitudinal impedance (ZL) as a measure of conduit-specific resistance and to evaluate its potential in predicting the outcome of infrainguinal vascular reconstructions.
Methods: ZL was measured during surgery in 73 infrainguinal autologous vein reconstructions performed in 68 patients in two separate institutions over a 21-month period. Vein graft ultrasonic transit time Q and Ap (from proximal to distal anastomosis) were measured at baseline and after maximal peripheral vasodilatation with an intraarterial injection of papaverine 30 mg. Waveforms were recorded for 10 seconds at 200 Hz using a digital acquisition system. R was calculated as proximal mean pressure divided by mean blood flow (Q). After Fourier transformation, ZL was calculated as A P / Q at each harmonic and total Z L (fZL) was defined as the integral of moduli from 0 to 4 Hz.
Results: All hemodynamic variables were significantly affected by papaverine vasodilatation (Ap, 3.9 +--0.5 vs 6.3 + 0.8 mm Hg; (~, 78.2 -7.0 vs 126 + 11 ml/min; R, 134 -17 vs 72.7 -6.2 × 103 dyne • sec • cm-S; p < 0.0001), except fZL, which remained constant (31.1 + 2.8 vs 30.8 -2.8 x 103 dyne" cm-S; p = NS). After follow-up o f l week to 17 months (median, 5 months), the 1-year primary, primary-assisted, and secondary patency rates were 72% -7%, 77% + 6%, and 81% ---6%, respectively. Using Cox analysis, primary patency was significantly associated with decreased fZ L (p = 0.0001), but not with baseline or papaverine-stimulated A~, (~, Ap/(~, or R. fZ L > 47 × 103 dyne. cm -s predicted primary failure with 90% positive and negative predictive value.
Conclusions: Intraoperative measurement of fZ L in infrainguinal vein grafts is independent of outflow conditions (that is, does not change with papaverine), and hence describes the resistive properties of the conduit only. In addition, these preliminary data suggest that fZ L is predictive of short-term primary patency, fZ L is the first available hemodynamic measurement that is conduit-specific and may therefore be a better predictor of graft patency than currently available methods. bypass attempts) 4 The mechanisms responsible for vein graft failure are poorly understood, although it has been suggested that the choice of conduit, adequacy of outflow, and the technical performance of the operation are the most critical factors.
Considerable effort has been directed toward the intraoperative evaluation of the adequacy ofrevascularization procedures. Currently available methods include completion angiography, sq° measurement of the mean blood flow, ~>~8 flow waveform shape, 19-2s flow velocity, 26'27 resistance, ls,28-41 and impedance} 8,4244 All methods have been found to correlate with outcome to some degree. Completion angiography provides an assessment of the technical adequacy of anastomoses but yields no physiologic information. Each of the hemodynamic variables describes, in some measure, the flow characteristics of the bypass graft and outflow system. However, each is exquisitely sensitive to outflow conditions, and wide fluctuations in each parameter are routinely observed with pharmacologic or physiologic vasodilatation. Therefore, the traditional hemodynamic measurements describe the properties of the conduit plus the outflow bed, and no variable is yet available that describes the hemodynamic properties of the conduit only. Because the adequacy of the bypass conduit is believed by many investigators to be one of the most critical elements of successful revascularization procedures, 1,45-49 accurate estimation of its specific resistive properties would be useful. The purpose of this study was to evaluate longitudinal impedance (ZL) as a measure of conduit-specific resistance and to evaluate its potential in predicting the outcome of infrainguinal vascular reconstruction procedures.
M E T H O D S
Patients who underwent autologous infrainguinal revascularization procedures at the Brigham and Women's Hospital (December 1994 to July 1995) or the University of Chicago (December 1995 to September 1996) were candidates for this study. Revascularization was performed in the standard fashion using reversed, in situ, or nonreversed greater saphenous, lesser saphenous, or upper extremity vein according to the preference of the surgeon. After completion of the anastomoses, two separate 22-gauge cannulas were filled with saline solution and connected to standard pressure tubing and fluid-filled pressure transducers (Hewlett-Packard; Palo Alto, Calif.). Each was calibrated to 100 mm Hg using a hand-held mercury manometer. The cannulas were inserted into preserved venous side branches near the proximal and distal anastomoses for the purpose of measuring proximal (Pprox) and distal (Pdist) intraluminal blood pressure. An ultrasonic transit-time probe (Transonics Systems, Inc., Ithaca, N.Y.) was used to measure blood flow (Q) in the region of the proximal vein graft (Fig. 1) . Pp .... Pdist, and Q waveforms were simultaneously recorded at 200 Hz for 10 seconds using a digital acquisition system (Lab Master D.M.A.; Scientific Solutions, Inc., Solon, Ohio). Data were obtained at baseline and after intragraft infusion ofpapaverine 30 mg (Eli Lilly & Co., Indianapolis, Ind.).
Hemodynamic calculations were performed after acquisition using software specifically designed for this purpose._Calculations included mean pressure difference (Ap), mean blood flow ((~), mean graft resistance (Ap/Q), outflow resistance (R), and longitudinal impedance (ZL). Rwas calculated as Pprox/ Q. Z L was calculated as Ap/Q at each harmonic after Fourier transformation of the respective waveforms. Fourier transformation is a mathematical technique that is useful for describing complex waveforms in more simple parameters. Complex waveforms in the time domain are broken down into a series of sine waves, each with a magnitude (modulus) and frequency. Details of the transformation are available elsewhere. 5°,51 After transformation of Ap and Q waveforms, a Z L curve was generated as Ap/Q at each harmonic, yielding the relationship of Z L to frequency (Fig. 2 ). The first value or "mean component" (Z L at 0 frequency) is simply Ap/Q or "mean graft resistance." It represents graft resistance during steady-state flow without pulsatile components. The remainder of the curve describes the relationship of Ap/Q during pulsatile flow. To obtain a single value for "vein graft longitudinal impedance" (fZL) , the area under the curve from 0 to 4 Hz was determined by integration. The calculations required approximately 10 seconds per data set to compute and were immediately available in the operating room for review. No grafts were modified or revised on the basis of impedance data. Data are presented as mean _+ SEM unless otherwise noted. Baseline and papaverine-stimulated hemodynamic measurements were compared using Student's t test for paired samples. Patency rates, limb salvage rates, and survival rates were calculated ~asing the life table method. 6 The effect of the clinical and hemodynamic variables on graft patency was assessed using either the log-rank test (for categorical variables) or the Cox method (for continuous variables). The significant covariates were then selected as candidate predictors for multiple regression analysis. Forward stepwise Cox regression analysis was performed by the likelihood ratio test. p values less than 0.05 were considered significant.
RESULTS
A total of 73 grafts in 68 patients were enrolled. A summary of patient and vein graft demographics are given in Tables I and II . Impedance measurements were performed without complication in all June 1997 patients; results are given in Table III . Stimulation resulted in stativtically significant increases in kp and 0 and a decrease in R. There was no statistically significant difference between baseline and stimulated Ap/Q or fZL. Mean follow-up was 6 -+ 1 months (median, 5 months; range, 1 week to 17 months). One-year primary patency, primary-assisted patency, secondary patency, limb salvage, and survival rates for the total patient group were 72% +-7%, 77% +-6%, 81% -+ 6%, 81% -+ 7%, and 88% -+ 5%, respectively (Fig. 3) . The secondary patency rate was equal to the limb salvage rate because two patients with end-stage renal failure required below-knee amputation despite patent grafts.
The results of univariate analysis relating clinical and hemodynamic variables to primary patency are shown in Table IV . Elevated baseline fZL, elevated baseline Ap, infrainguinal proximal anastomosis level, elevated baseline AP/Q, and elevated stimulated Ap were all associated with decreased primary patency rates. Using multiple regression analysis, however, only baseline fZ L was significantly related to primary patency (p = 0.0001; Fig. 4 ). Although it was not statistically significant, veins that had been grafted into high-resistance outflow beds (as defined by stimulated R > 50 × 103 dyne • sec • cmS) 44 appeared to have less favorable patency rates than grafts placed into low-resistance circuits (Fig. 5) .
Multiple regression analysis relating clinical and hemodynamic parameters to survival yielded advanced age (p = 0.0062) and the presence of endstage renal failure (p = 0.014) as the only independent predictors of death. None of the intraoperative hemodynamic measurements were related to survival by univariate or multiple regression analysis.
A cut-off level of fZ L was retrospectively chosen in an attempt to devise a useful clinical test. Grafts that were patent for at least 5 months (median follow-up) and all failed grafts were included in predic- rive value analysis. A fZ L value greater than 47 × 103 dyne • cm -5 had a 90% positive and negative predictive value for primary failure.
DISCUSSION
The safety and efficacy of infrainguinal bypass grafting procedures have improved markedly in recent years. In large series, the mortality rate from infrainguinal bypass grafting approaches 2%, with the major morbidity rate estimated at about 7%. 4 The risk of immediate graft failure and limb loss remains at about 7%. The long-term outcome for infrainguinal bypass procedures has also improved markedly, although failure rates varying from 20% to 40% at 5 years are consistently reported. programs become more aggressive and grafts are placed to more distal vessels, the need for proper patient and conduit selection has become paramount. Considerable attention has been given to the intraoperative assessment ofinfrainguinal revascularization procedures in an attempt to minimize postoperative failure. Early studies focused on the measurement of 0 by electromagnetic flowimetry, 2 and the results indicated that grafts with adequate levels of 0 exhibited superior patency rates at 3 months il,13,17 and 1 year. ls,17,a2 More recent efforts have addressed the concept of functional "runotP' assessment through measurement of 1k A variety of methods of R estimation have been devised, with variable results. 29,31,33,36,s8,39,41 The available data suggest that high R correlates with graft failure at 1 month, s8 3 months, 29 4 months, sl and i year. ss Its sensitivity and specificity are fairly low, however. 4,12-15,17,18,sz,s6, 42, 52, 53 A recent study concluded that a stimulated R value greater than 50 × l0 s dyne-sec" cm -s was 71% sensitive and 65% specific for graft failure at 2 years. 44 This finding was reproduced in the present series ( Fig. 5) . Although the association is convincing, the fact that a significant number of grafts placed into high-resistive circuits remain patent limits its usefulness as a clinical test. One possible explanation for the low sensitivity and specificity of Q and R measurements for graft failure is that they are strongly dependent on the resistive properties of the outflow bed and only wealdy dependent on the quality of the conduit. This can easily be demonstrated by infusion of peripheral vasodilators, which have relatively little effect on the conduit but can change Ap, Q, and R by 100% (Table III) . This report contains the first description, to our lmowledge, ofhemodynamic variables that are conduit-specific; that is, unaffected by changes in peripheral resistance. Vasodilatation increases both Ap and Q, but their ratio remains constant (Table  III) . Traditionally, only the mean components of vein graft resistance have been calculated (Ap/Q), although this method ignores the pulsatile nature of blood flow within grafts. Because the magnitude of the p ulsatile components of AP/Q actually exceed AP/Q (just as the systolic AP routinely exceeds AP), it seems reasonable to include the higher-frequency components of Ap/Q when evaluating the ability of a vein graft to carry blood, s4 Furthermore, in lowflow states, in conduits of a reasonable size, AP can be quite small and difficult to measure precisely, whereas the higher harmonics of Ap are greater in magnitude and can be measured with a lower signalto-noise ratio. The calculation of fZ L is therefore quite reproducible even with profound changes in Ap, Q, and Rinduced by papaverine (Fig. 2, D) . For these reasons, it is hypothesized that fZ L more accurately reflects vein graft resistance than more traditional variables, ss Given the strong dependence of successful revascularization procedures on conduit quality and given the conduit-specific nature offZ D it is not surprising that fZ L is a strong predictor of graft patency. Of all of the clinical and hemodynamic parameters examined in this study, only fZ L was significantly associated with primary patency by multiple regression analysis. Of the 13 grafts in this series with high fZD nine failed primarily in less than 4 months. Two of the primary failures achieved primary-assisted pa- tency through vein patch angioplasty, although one patient eventually required below-knee amputation with a patent graft. The other seven failures were treated by revascularization procedures with a new conduit (2), amputation (3), or observation (2). Four grafts that had high fZL remain patent at 1, 4, 5, and 8 months, although one graft shows increased peak systolic velocity on duplex scan and revision is planned. In contrast, of the 60 grafts that had low fZL, only five failed, and three of the failures remain secondarily patent after thrombectomy, revision, or both. Thus a good quality conduit with a low fZ L can often be successfully salvaged after an episode of thrombosis. As expected, none of the hemodynamic parameters were associated with patient survival, although advanced age and the presence of end-stage renal failure were significant independent predictors of death.
CONCLUSION
Intraoperative measurement of fZ L in infrainguinal vein grafts is independent of outflow conditions and therefore describes the resistive properties of the conduit only. These preliminary data suggest that fZ L is predictive of short-term primary patency, fZ L is the first available hemodynamic measurement that is conduit-specific and may therefore be a better predictor of graft patency than currently available methods.
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DISCUSSION
Dr. William M. Abbott (Boston, Mass.). As many of you know, this is an area of longstanding interest of mine and our research group, and I think this is a wonderful piece of work. I congratulate you on it.
We tried to do this a number of years ago, and success was limited by virtue of technology. What you've done is take modern methods and prove what the mechanical engineers have known for years, that resistance is bad for .continuing blood flow. You have identified a group of high-impedance veins that are destined to do poorly and some low-impedance veins that are destined to do well. Of course, as I am sure you are also well aware, one of the things that governs impedance is not only the flow dynamics themselves but the wall mechanical properties. And as I am sure you are also aware, in the absence of diameter mismatches, that is stenoses, the likely cause of your high impedance is low compliance of the vein wall. So I think it would be a very interesting next step, if you haven't already done it, to correlate the viscoelastic or compliance properties of the conduits with your results. Once you do that, I think that you'll then be able, in the operating room, to have identified a set of circumstances that will at least let you say to yourself when you leave the operating room, "if this doesn't work, I have to do something totally different rather than spending a long period of time trying to fix the problem, because it's fundamentally a bad conduit."
The other thing that I think would be very interesting for you to do, because the compliance values of prostheses are so much different than that of vein, would be to compare those. It has been a longstanding hypothesis of ours that compliance mismatch is one of the contributors to the poor results of prosthetic bypass grafts in the lower extremities. Thus I would ask you whether you've had any experience in doing these measurements in prostheses.
Dr. Lewis B. Schwartz. We have actually approached both of those issues, the first being the possible relationship with viscoelastic properties. We have set up an in vitro system in the laboratory, and because the longitudinal impedance is independent of both the input and outflow conditions, it is very easy to measure longitudinal impedance in the laboratory. We have been unable to correlate longitudinal impedance with diameter, interestingly, although our sample size is small. We have also been unable to correlate ZLwith wall characteristics up to this point, but I agree completely that compliance is going to be a major determinant of longitudinal impedance and vice versa.
As far as prosthetic grafts, we have done two intraoperative measurements of polytetrafluoroethylene grafts, and the resistance is very low. It is a very large conduit, and there is practically no pressure gradient. It is interesting that the shape of the curve does not approach the shape of a vein graft curve. It's perfectly fiat all across the frequency spectrum. I don't know whether that has anything to do with its propensity to failure, but it is a very, if you'll excuse the term, unnatural-appearing longitudinal impedance curve, so we are currently investigating that as well.
Dr. James O. Menzoian (Boston, Mass.). This is a very interesting paper, Dr. Schwartz, and I think that any time you hear about what keeps grafts open or why grafts fail it gets our attention. My own interest in measuring the runoff stems back many years ago when Dr. Mannick used to measure flow in all the vein grafts he did, and I was really impressed by the fact that in those days when we performed bypass procedures to an isolated popliteal segment and the flow in the graft was extremely low--20 or 25 ml--and those grafts would still stay open. So I sort of came to the conclusion, and he taught me that vein grafts are good and that there "ain't nothing like the real thing, baby." I may have taken a little liberty with what Dr. Mannick actually said, but vein grafts are good.
Dr. John A. Mannick (Boston, Mass.). I wish I would have said that.
Dr. Menzoian. There are a couple of things that I don't understand here. This impedance is actually a calculated value and you calculate it from Ap and you calculate it from flow, and yet when you correlated what kept a graft patent, the only thing that correlated was the impedance value and it didn't correlate with change in pressure and it didn't correlate with flow. Somehow, I don't understand the math of that. If they are related and all calculated, why don't they all correlate?
Dr. Schwartz. The reason is that it is not really important what the flow is. You yourself said grafts with low flow stay open, and if you don't like the flow that you have in your bypass graft, give some papaverine and the flow will go up. The change in pressure is not really important either, because at low flow the change in pressure will be low and if you stimulate flow the change in pressure will be higher. What's important is the ratio of those two. It is the ratio of the change in pressure to flow, and that is why in a multivariate analysis both flow and the change in pressure will cancel out, but their quotient will remain important.
Dr. Menzoian. Another interesting point, if I may continue, I was really intrigued by the fact that nothing correlated with patency other than this measurement, not diabetes, not renal failure, not above-knee, not in situ, not reversed. Nothing correlated other than this measurement. Weren't you a little surprised by that?
Dr. Schwartz.. The data are the data, but I will add that none of those variables correlate with longitudinal impedance, either. We looked whether cephalic veins had a lower longitudinal impedance because they were larger. That doesn't hold true. Maybe veins had a different longitudinal impedance depending on whether or not you had diabetes or high blood pressure. That doesn't seem to hold true, and it sort of goes with the clinical observation that it's a little hard to predict who will have a good vein and who will have a bad vein. Even with vein mapping, frankly, I find it hard to predict.
Dr. Menzoian. What you are saying is that this measurement of a 60 cm long graft is more important than the entire runoff bed, which is probably a couple of million miles of capillaries. That's a little interesting to me. Why do you think that is the case? Dr. Schwartz. Well, I think there are many people in this room who think that the quality of the vein is maybe the most or one of the most important factors in bypass grafting. You say yourself, Dr. Menzoian, that grafts with very low flow can still stay open if it's a good vein. So I frankly am not surprised at the relative importance of something that measures the quality of the vein compared to something that measures the quality of the outflow.
Dr. George D. LeMaitre (North Andover, Mass.). I congratulate the authors on attempting to derive physiologic data during surgery on bypass grafts. That's the way to go in the future.
In our operating room, we simultaneously measure proximal and distal graft flow to gauge the significance of the residual fistulae that we leave behind. Needless to say, the more fistulae, or the more significant they are, or the less resistance to flow in them, the more discrepancy we end up with between the two flowmeters, and that helps to determine whether we have to bother ligating them. Were any of the grafts in your series in situ grafts, and if so were fistulae there when you made your measurements? Dr. Schwartz. They were all tied off. Some grafts were , performed in situ, but all the fistulae were fled. Dr, LeMaitre. When they were in situ they were all tied off, which was a pure vein measurement? Dr. Schwartz. Yes. I wouldn't know how to interpret the data otherwise.
Dr, Frank W. LoGerfo (Boston, Mass.). When you talk about resistance, are you talldng about resistance across the graft? Dr. Schwartz. Yes. Dr, LoGerfo. And there is no relationship between resistance across the graft and graft patency, but there is a relationship between the longitudinal impedance and graft patency?
Dr. Schwartz. Longitudinal impedance and resistance across the graft are synonymous, so there is a relationship between resistance across the graft.
Dr. LoGerfo. So why don't we just measure pressure and flow across the graft? Dr. Schwartz. If you have a graft that is about 4 mm in diameter and it has 50 ml/min of flow going through it, then the mean pressure difference will only be about 1, and it's very difficult to measure that very accurately. We know that mean pressure differences are not that important because we often talk about systolic pressure differences. In other words, the difference in pressure at 1 Hz is more important than the difference in pressure at the mean value, and so it is much easier if you take the entire flow wave form to measure the pressure difference across the graft, and the reason we measure harmonics at all is because it turns out to be more precise than just measuring a simple mean pressure difference.
Dr. William W. Babson, Jr. (Plymouth, Mass.). I think this is an exciting paper because one thing it might do is take the onus of thrombosed graft from the technical aspects of the surgeon and put it on the graft, but the question that I have is what do you mean by measuring at different harmonics? How do you determine what harmonic? What is 1 Hz and 4 Hz? What does that mean?
Dr. Schwartz. It would take a couple of hours and people a lot smarter than me to explain that, but blood flows at say 60 beats per minute and the peak of that would be 300 ml per minute, whereas the mean might be 50 ml per minute. Well, if you only measure the mean and that's at 0 harmonic or 0 frequency, you are missing all this information that is contained within this wave form that is very complex, and Fourier analysis is a way to take that complex wave form in a time domain and transform it into a frequency domain, so we can talk about the component at 1 Hz or the fundamental frequency, the component at 2 Hz, 3 Hz, because these wave forms have very complex components to them, so you are missing all this information by simply taking the mean component at 0 Hz.
Dr. Frank J. Veith (Bronx, N.Y.). You say that the impedance did not correlate with the diameter of the vein. Did you look also at the disease within the vein that may have accounted for this impedance? Maybe you are just picldng up those veins that have preexisting syncytial webs and other luminal lesions. I believe it would be interesting to use angioscopy and see whether there is an anatomic reason within the vein graft that produced the high impedance. Did you do that at all? Any idea of pathologic characteristics?
Dr. Schwartz. We did not. Dr. Veith. I believe there is something inside the vein or the vein wall that accounts for this, and I believe you have a sophisticated way of detecting that.
Dr. Schwartz. Well, I agree completely.
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